Physician profile

Stewart A Skipper

Surgery · Sebring, FL

NPI 1427091073

$1,304.63

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$557.95
Food and Beverage$425.25

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Biotronik INC. $1,013.02 2021-2024 Solia, Selectra, Biomonitor
Smith+Nephew, INC. $144.78 2019
Ethicon US, LLC $58.98 2021-2024 Enseal X1, Echelon Circular
Medtronic Vascular, INC. $32.20 2019-2020
Cvrx, INC. $21.26 2021
Innocoll Pharmaceuticals Limited $18.36 2021
Silk Road Medical, INC. $16.03 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Stewart A Skipper

$1,304.63

in general payments reported 2019-2025

Years
2019-2024
Top company
Biotronik INC.

https://glasscript.com/doctor/337271/stewart-a-skipper

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.